Processes for incorporating nucleic acid sequences into an analyte or library of analytes

• US 7,858,302 B2
• Filed: 09/27/2005
• Issued: 12/28/2010
• Est. Priority Date: 03/12/2002
• Status: Active Grant

• Current Assignee: Enzo Life Sciences Incorporated (Enzo Biochem Incorporated)
• Original Assignee: Enzo Life Sciences Incorporated (Enzo Biochem Incorporated)
• Inventors: Stavrianopoulos, Jannis G., Donegan, James J., Rabbani, Elazar, Coleman, Jack, Liu, Dakai
• Primary Examiner(s): Chunduru; Suryaprabha
• Application Number:
  US11/237,466
• Publication Number:
  US 20060035264A1
• Time in Patent Office: 1,918 Days
• Field of Search: 435/6, 435/91.2, 536/24.33, 536/23.1, 536/22.1
• US Class Current: 435/6.18
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 2533/101 Primer extension
• CPC Class Codes: C12Q 2561/113 Real time assay
• CPC Class Codes: C12Q 2565/101 Interaction between at least two labels
• CPC Class Codes: G01N 21/64 Fluorescence; Phosphorescence
• CPC Class Codes: G01N 21/6486 Measuring fluorescence of biological material, e.g. DNA, RNA, cells G01N21/6428 takes precedence

Abstract

This invention provides for compositions for use in real time nucleic acid detection processes. Such real time nucleic acid detection processes are carried out with energy transfer elements attached to nucleic acid primers, nucleotides, nucleic acid probes or nucleic acid binding agents. Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample. Other processes are provided by this invention including processes for removing a portion of a homopolymeric sequence, e.g., poly A sequence or tail, from an analyte or library of analytes. Compositions useful in carrying out such removal processes are also described and provided.

Claims

1. A process for incorporating a desirable nucleic acid sequence into an analyte or a library of analytes, said process comprising the steps of:

a) providing

(i) said analyte or library of analytes;

(ii) a chimeric nucleic acid comprising at least two segments, the first segment comprising five or more universal bases and the second segment comprising a template for synthesizing said desirable nucleic acid sequence wherein said chimeric nucleic acid is incapable of strand extension; and

(iii) reagents for carrying out hybridization and template-dependent strand extension;

b) binding or hybridizing said chimeric nucleic acid (ii) to said analyte or library of analytes (i); and

c) extending the 3′

end of said analyte or library of analytes;

wherein said second segment is a template for said extending step (c) when said second segment is in proximity to the 3′

end of said analyte or library of analytes.

2. The process of claim 1, wherein the 5′

end of said first segment is attached to the 3′

end of said second segment.

3. The process of claim 1, wherein said desirable nucleic acid sequence comprises at least one primer binding sequence or promoter sequence.

4. The process of claim 3, wherein said primer binding sequence is homopolymeric or heteropolymeric.

5. The process of claim 4, wherein said homopolymeric sequence comprises poly T, poly U, poly G, poly C or poly A.

6. The process of claim 4, wherein said heteropolymeric sequence comprises an RNA promoter sequence.

7. The process of claim 6, wherein said RNA promoter sequence comprises a T3 promoter, a T7 promoter or an SP6 promoter.

8. The process of claim 1, wherein in said providing step (a), the analyte or library of analytes (i) comprise DNA or RNA.

9. The process of claim 8, wherein said DNA comprises chromosomal DNA, episomal DNA or viral DNA.

10. The process of claim 8, wherein said RNA comprises mRNA, hRNA, snRNA, rRNA, tRNA or viral RNA.

11. The process of claim 1, wherein in said providing step (a), the DNA or RNA is or has been fragmented.

12. The process of claim 11, wherein said fragmentation has been carried out by a chemical, physical or enzymatic process.

13. The process of claim 12, wherein said enzymatic process is carried out by an endonuclease.

14. The process of claim 1, wherein in said providing step (a) the first segment comprises from eight to fifteen universal bases.

15. The process of claim 1, wherein in said providing step (a) the universal bases comprise inosine, 5-nitroindole or 3-nitropyrrole.

16. The process of claim 1, wherein in said providing step (a) the reagents (iii) comprise polymerases or ligases.

17. The process of claim 16, wherein said polymerases comprise reverse transcriptases, DNA Pol I or Klenow fragment of Pol I.

18. The process of claim 16, wherein said ligases comprise T4 DNA ligase.

19. The process of claim 1, wherein said reagents (iii) comprise one or more labeled nucleotides or oligonucleotides.

20. The process of claim 1, wherein said binding or hybridizing step (b) is carried at or near a temperature and under conditions sufficient to form a stable complex or hybrid between said chimeric nucleic acid (ii) and said analyte or library of analytes (i).

21. The process of claim 1, further comprising the step (a′

) of pretreating said analyte or library of analytes with a phosphatase.

22. A process for incorporating a desirable nucleic acid sequence into an analyte or a library of analytes, said process comprising the steps of:

a) providing

(i) said analyte or library of analytes;

(ii) a set of chimeric nucleic acids, each such nucleic acid comprising at least three segments, the first segment comprising four or more universal bases, the second segment comprising permutations of from one to eight nucleotides, the third segment comprising a template for synthesizing said desirable nucleic acid sequence,

wherein in said second segment, the permutations of from one to eight nucleotides comprise

(N)_n

wherein N independently comprises G, A, T or C, and wherein n is an integer from one to eight and wherein said chimeric nucleic acid is or has been rendered incapable of strand extension; and

(iii) reagents for carrying out hybridization and template-dependent strand extension;

b) binding or hybridizing said chimeric nucleic acids (ii) to said analyte or library of analytes (i); and

c) extending the 3′

end of said analyte or library of analytes;

wherein said third segment is a template for said extending step (c) when said second segment is hybridized to the 3′

end of said analyte or library of analytes.

23. The process of claim 22, wherein in said providing step (a), for each such chimeric nucleic acid, the 5′

end of said first segment is attached to the 3′

end of said second segment, and the 5′

end of said second segment is attached to the 3′

end of said third segment.

24. The process of claim 22, wherein said desirable nucleic acid sequence comprises at least one primer binding sequence or promoter sequence.

25. The process of claim 24, wherein said primer binding sequence is homopolymeric or heteropolymeric.

26. The process of claim 25, wherein said homopolymeric sequence comprises poly T, poly U, poly G, poly C or poly A.

27. The process of claim 25, wherein said heteropolymeric sequence comprises an RNA promoter sequence.

28. The process of claim 27, wherein said RNA promoter sequence comprises a T3 promoter, a T7 promoter or an SP6 promoter.

29. The process of claim 22, wherein in said providing step (a), the analyte or library of analytes (i) comprise DNA or RNA.

30. The process of claim 29, wherein said DNA comprises chromosomal DNA, episomal DNA or viral DNA.

31. The process of claim 29, wherein said RNA comprises mRNA, hRNA, snRNA, rRNA, tRNA or viral RNA.

32. The process of claim 22, wherein in said providing step (a), the DNA or RNA is or has been fragmented.

33. The process of claim 32, wherein said fragmentation has been carried out by a chemical, physical or enzymatic process.

34. The process of claim 33, wherein said enzymatic process is carried out by an endonuclease.

35. The process of claim 22, wherein in said providing step (a) the first segment comprises from six to fifteen universal bases.

36. The process of claim 22, wherein in said providing step (a) the first segment comprises four universal bases and n is 4.

37. The process of claim 22, wherein in said providing step (a) the first segment comprises four universal bases and n is 6.

38. The process of claim 22, wherein in said providing step (a) the universal bases comprise inosine, 5-nitroindole or 3-nitropyrrole.

39. The process of claim 22, wherein in said providing step (a) the reagents (iii) comprise polymerases or ligases.

40. The process of claim 39, wherein said polymerases comprise reverse transcriptases, DNA Pol I or Klenow fragment of Pol I.

41. The process of claim 40, wherein said ligases comprise T4 DNA ligase.

42. The process of claim 22, wherein said reagents (iii) comprise one or more labeled nucleotides or oligonucleotides.

43. The process of claim 22, wherein said binding or hybridizing step (b) is carried at or near a temperature and under conditions sufficient to form a stable complex or hybrid between said chimeric nucleic acids (ii) and said analyte or library of analytes (i).

44. The process of claim 22, further comprising the step (a′

) of pretreating said analyte or library of analytes with a phosphatase.

45. A process for incorporating a desirable nucleic acid sequence into an analyte or a library of analytes, said process comprising the steps of:

(a) providing;

(i) said analyte or library of analytes;

(ii) a chimeric nucleic acid comprising at least two segments, wherein the first of said two segments is complementary to a first portion of said analyte nucleic acid sequence, wherein the second of said two segments is complementary to a second portion of said analyte nucleic acid sequence and wherein said chimeric nucleic acid is or has been rendered incapable of strand extension;

(iii) reagents for hybridization and endonucleolytic digestion;

(iv) an endonuclease; and

(v) reagents for strand extension;

(b) forming a mixture comprising (i), (ii), (iii) and (iv);

(c) hybridizing said chimeric nucleic acid (ii) with said analyte or library of analytes (i), thereby forming a first complex between said first segment and said first portion of said analyte, and a second complex between said second segment and said second portion of said analyte;

wherein said first portion is resistant to digestion by said endonuclease, and wherein said second portion comprises one or more sites sensitive to endonucleolytic digestion;

(d) digesting said second portion with said endonuclease (iv); and

(e) extending the 3′

-end of said second portion, said 3′

-end having been generated by said endonuclease (iv),

wherein said extending step (e) is carried out by template dependent polymerization or ligation.

46. The process of claim 45, wherein in the providing step (a), said analyte or library of analytes (i) comprise DNA, RNA, or a mixture of DNA and RNA.

47. The process of claim 45, wherein in the providing step (a), said first segment, said first analyte nucleic acid sequence comprises RNA, said second segment comprises DNA, said second analyte nucleic acid sequence comprise RNA and said endonuclease (iv) comprises RNase H.

48. The process of claim 45, wherein in the providing step (a), said second segment and said second analyte nucleic acid sequence comprise a recognition sequence for an asymmetric restriction enzyme.

49. The process of claim 48, wherein said asymmetric restriction enzyme comprises N. BstN B I.

50. The process of claim 45, wherein in the providing step (a), said first segment comprises modified nucleotides or nucleotide analogs that confer resistance to digestion by said endonuclease (iv).

51. The process of claim 45, wherein in the forming step (b), (i), (ii) and (iii) are mixed together, and then (iv) and (v) are added after said hybridizing step (c).

52. The process of claim 45, wherein in the forming step (b), (i), (ii), (iii) and (v) are mixed together, and then (iv) is added after said hybridizing step (c).

53. The process of claim 45, wherein said strand extending step (e) also comprises strand displacement.

54. The process of claim 45, further comprising the step (f) of carrying out a dephosphorylation step.

55. The process of claim 45, wherein said chimeric nucleic acid (ii) further comprises a third segment complementary to a third portion of said analyte nucleic acid sequence, and wherein said hybridizing step (c) further comprises forming a third complex between said third segment and said third portion, wherein said third portion is resistant to digestion by said endonuclease.

56. The process of claim 55, wherein in the providing step (a) said third segment comprises modified nucleotides or nucleotide analogs which confer resistance to digestion by said endonuclease (iv).

57. The process of claim 45, wherein said chimeric nucleic acid (ii) further comprises a third segment non-complementary to said analyte or library of analytes.

58. The process of claim 57, wherein said third segment comprises a primer binding site or an RNA promoter sequence.

59. The process of claim 45, wherein the providing step (a) said analyte or library of analytes (i) have been fragmented.

60. The process of claim 49, wherein said analyte or library of analytes (i) have been fragmented by an endonuclease.

61. The process of claim 60, wherein said endonuclease comprises RNase, DNase, S1 nuclease, mung bean nuclease or a restriction enzyme.

62. The process of claim 45, wherein said reagents for strand extension comprise one or more labeled nucleotides or labeled oligonucleotides.